5:00 PM
 | 
Mar 29, 2013
 |  BC Extra  |  Politics & Policy

FDA issues draft guidance on biosimilar meetings

FDA published draft guidance on Friday that provides standards for biosimilar product sponsors and applicants to follow while requesting,...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >